Targeting BCL-2 family proteins to overc
β
Emmanuelle Wesarg; Sandra Hoffarth; Rainer Wiewrodt; Monika KrΓΆll; Stefan Bieste
π
Article
π
2007
π
John Wiley and Sons
π
French
β 422 KB
## Abstract Cytotoxic chemotherapies are standard of care for patients suffering from advanced nonβsmall cell lung cancer (NSCLC). However, objective responses are only achieved in 20% of cases and longβterm survival is rarely observed. Clinically applied anticancer drugs exert at least some of the